Directed differentiation of embryonic stem cells into bladder tissue.
about
Regenerative medicine in urologyThe epidermal differentiation-associated Grainyhead gene Get1/Grhl3 also regulates urothelial differentiationLoss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium.Induction of human embryonic and induced pluripotent stem cells into urothelium.Cell biology and physiology of the uroepithelium.Activin alters the kinetics of endoderm induction in embryonic stem cells cultured on collagen gels.Generation of bladder urothelium from human pluripotent stem cells under chemically defined serum- and feeder-free system.Generation of human female reproductive tract epithelium from human embryonic stem cells.All-trans retinoic acid directs urothelial specification of murine embryonic stem cells via GATA4/6 signaling mechanisms.GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgensClonal, self-renewing and differentiating human and porcine urothelial cells, a novel stem cell population.Regenerative medicine strategies for treating neurogenic bladderLoss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cellsUrothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling.Spermatogonial stem cells, in vivo transdifferentiation and human regenerative medicine.Tissue engineering of human bladder.An examination of regenerative medicine-based strategies for the urinary bladder.When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.Regenerative medicine as a new therapeutic strategy for lower urinary tract dysfunction.Cell-Based Therapies in Lower Urinary Tract Disorders.Production of urothelium from pluripotent stem cells for regenerative applications.FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation.On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.Bladder expression of CD cell surface antigens and cell-type-specific transcriptomes.Differentiation of human endometrial stem cells into urothelial cells on a three-dimensional nanofibrous silk-collagen scaffold: an autologous cell resource for reconstruction of the urinary bladder wall.Scaffold Characteristics for Functional Hollow Organ Regeneration.The Current Use of Stem Cells in Bladder Tissue Regeneration and Bioengineering.Comparison of Teratoma Formation between Embryonic Stem Cells and Parthenogenetic Embryonic Stem Cells by Molecular Imaging.
P2860
Q27006859-2BAC3F4D-77C5-49B3-AF02-DAD2B70F2E3FQ28590746-83C68534-5763-4B82-AEEF-1392202FA8EFQ28730032-45234D09-D859-47A1-90B6-5592B11A94F1Q33362673-B11B2609-5847-44BC-B72C-C59298075F1EQ33551978-AE51A840-3773-4BBD-BA10-DEFE0067E884Q33570078-0C105C77-3658-4206-8140-C828C47EB76CQ33575394-DBEAA3DA-ED88-4E5D-85AE-F90D3FE27B41Q33755507-A350D30F-443F-45E6-B81B-B89ABBFB0A7CQ33941198-C7114CBB-E322-488C-A36C-3A9AA86D34C6Q33991635-358BBE37-FEEC-4E2E-87AC-FAE6412B585AQ34178465-D33D0478-4D35-45B0-8F64-26570BACC821Q35108553-406B95F2-2C7A-4FEF-B801-89C9BE450E24Q35539602-2F7F136D-7187-412C-91C0-5B36E7B44948Q35568071-7B0482E9-739C-401E-864C-7D2187CEEAEAQ36945929-6D0EC145-3283-4911-A04C-BF0EC60B48C2Q37286523-04BAF36B-B018-4A4D-8C0D-E3CA55ABF587Q37322183-42AB4EB9-3113-4E84-8922-8425C06831B9Q37690326-3AF1E5F7-23CD-4A8D-9BEE-1B510C02630FQ37843029-080DDE43-AF54-463F-A1AE-441D8A0AD545Q37931910-2EAE5D88-17BA-4DA0-B723-429C0595168BQ37933675-208531BC-FB9D-4676-96AC-B4407128269CQ38099676-072C7078-2241-4CDB-ABE5-955EAA2A7970Q38257799-7B222837-07AC-4520-BF87-A8E196B8D3EEQ38268939-3CEF95F0-4F19-4BE8-B415-46FB0216E0FCQ38288442-A629523D-CE87-4EBC-92B2-7FBEFCB70210Q38789453-8C4BB5E5-5704-4526-90DD-E702FF7CAD0BQ41771188-43944CEC-C202-4927-96E4-4FA551B0143DQ46057054-7634BD13-C469-4D8E-80D9-2099158AFDAFQ47110372-6BAAB313-96A2-4FF0-A0EE-E527CA810D77Q50865542-DC17273A-B64A-47A4-BDCA-51739E20D094Q54961506-04BD5210-BC40-4215-A4C1-9F6D0625D484
P2860
Directed differentiation of embryonic stem cells into bladder tissue.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Directed differentiation of embryonic stem cells into bladder tissue.
@ast
Directed differentiation of embryonic stem cells into bladder tissue.
@en
type
label
Directed differentiation of embryonic stem cells into bladder tissue.
@ast
Directed differentiation of embryonic stem cells into bladder tissue.
@en
prefLabel
Directed differentiation of embryonic stem cells into bladder tissue.
@ast
Directed differentiation of embryonic stem cells into bladder tissue.
@en
P2093
P2860
P50
P1476
Directed differentiation of embryonic stem cells into bladder tissue.
@en
P2093
Ali-Reza Sharif-Afshar
John C Pope
John C Thomas
John H Makari
John W Brock
Katrina Saba
Marcia L Wills
Neil A Bhowmick
Omar E Franco
Robert J Matusik
P2860
P304
P356
10.1016/J.YDBIO.2007.01.010
P407
P577
2007-01-12T00:00:00Z